InsidersTradesSigma
Follow the 拱东医疗 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 拱东医疗 has recorded 11 insider filings. Market capitalisation: €3.5bn. The latest transaction was reported on 1 April 2025 (Sale). Among the most active insiders: 钟卫峰. The full history is free.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€768,373
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,868 of 28,857 companies
44.7
score / 100
Value41
Quality48
FCF yld4.1%
Earn yld1.5%
EV/EBITDA21.6x
ROE3.2%
Gross mgn28%
Net mgn4.5%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2025
Declarations11 total
11 of 11 declarations
About 拱东医疗
拱东医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and distribution of innovative medical products.